Literature DB >> 22301017

[State of acute phase markers and oxidative stress in patients with kidney stones in the urinary tract].

J Carrasco-Valiente1, F J Anglada-Curado, P Aguilar-Melero, R González-Ojeda, J Muntané-Relat, F J Padillo-Ruiz, M J Requena-Tapia.   

Abstract

OBJECTIVE: This present study has aimed to assess the state of acute phase markers and oxidative stress in patients with kidney stones.
MATERIAL AND METHODS: A prospective study was carried out on 100 patients with kidney stones and 25 healthy controls. Albumin, ß2 microglobulin, Gamma-glutamyl transpepsidase, Lactate dehydrogenase, Tumor necrosis factor alpha, Interleukin 1 and Interleukin-6 were evaluated as acute phase markers and lipid peroxidation products, Superoxide dismutase and Glutathione peroxidase levels acted as oxidative stress markers.
RESULTS: An increase in renal cell damage markers as expressed by the ß2 microglobulin (p=0.04), albumin (p=0.004), Lactate dehydrogenase (p=0.001) and Gamma glutamyl transpepsidasa (p=0.01) was observed in the patient group. There was a direct correlation between levels of ß2 microglobulin and stone size (r=0.3, p=0.03). The association between stone size and cytokine activation was observed to be stronger in patients with staghorn calculi. In these patients, Tumor necrosis factor alpha (p=0.011), Interleukin 1 (p=0.004) and Interleukin 6 (p=0.004) were significantly higher. Patients with stones in the urinary tract showed data of significantly higher oxidative stress, expressed as an increase in levels of lipid peroxidation products (p=0.03) and a decrease in the antioxidant activity of Superoxide dismutase (p=0.03) and Glutathione peroxidase (p=0.002).
CONCLUSIONS: Patients undergoing urolithiasis showed an elevation of acute phase markers, associated with oxidative stress as expressed by an increase in lipid peroxidation products and a decrease in the antioxidant enzyme activity.
Copyright © 2011 AEU. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22301017     DOI: 10.1016/j.acuro.2011.08.004

Source DB:  PubMed          Journal:  Actas Urol Esp        ISSN: 0210-4806            Impact factor:   0.994


  7 in total

1.  Increased risk of bone fracture among patients with urinary calculi: a nationwide longitudinal population-based study.

Authors:  S-M Ou; Y-T Chen; C-J Shih; D-C Tarng
Journal:  Osteoporos Int       Date:  2014-12-19       Impact factor: 4.507

2.  Is oxidative stress related to childhood urolithiasis?

Authors:  Nilufer Göknar; Faruk Oktem; Engin Arı; Aysegul Doğan Demir; Emel Torun
Journal:  Pediatr Nephrol       Date:  2014-02-14       Impact factor: 3.714

3.  Antioxidant therapy prevents ethylene glycol-induced renal calcium oxalate crystal deposition in Wistar rats.

Authors:  Mohammad Reza Naghii; Eslam Eskandari; Mahmood Mofid; Mehdi Jafari; Mohammad Hossein Asadi
Journal:  Int Urol Nephrol       Date:  2014-02-20       Impact factor: 2.370

4.  Association study of DGKH gene polymorphisms with calcium oxalate stone in Chinese population.

Authors:  Yong Xu; Guohua Zeng; Zanlin Mai; Lili Ou
Journal:  Urolithiasis       Date:  2014-08-01       Impact factor: 3.436

5.  Urinary calculi and risk of cancer: a nationwide population-based study.

Authors:  Chia-Jen Shih; Yung-Tai Chen; Shuo-Ming Ou; Wu-Chang Yang; Tzeng-Ji Chen; Der-Cherng Tarng
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

6.  Effects of short-term atorvastatin use in patients with calcium stones: A randomized placebo-controlled clinical trial.

Authors:  Fatemeh Taheri; Maryam Taheri; Abbas Basiri; Alireza Khoshdel; Fariba Samadian; Sanaz Tavasoli
Journal:  Investig Clin Urol       Date:  2019-10-22

7.  Relationship Between Urolithiasis and Fatty Liver Disease: Findings in Computed Tomography.

Authors:  Federico Guillermo Lubinus Badillo; Oscar Leonel Ortiz Cala; Silvia Nathalia Vera Campos; Erick Daniel Villarreal Ibañez
Journal:  Tomography       Date:  2020-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.